Cholestech to Present at the Pacific Growth Equities' Life Sciences Growth Conference
06 Juni 2006 - 1:38AM
PR Newswire (US)
HAYWARD, Calif., June 5 /PRNewswire-FirstCall/ -- Cholestech
Corporation (NASDAQ:CTEC), a leading manufacturer of point of care
testing devices, today announced that Warren E. Pinckert II,
President and CEO and Jack F. Glenn, CFO, will present at the
Pacific Growth Equities' Life Sciences Growth Conference on
Tuesday, June 13, 2006, at 2:30 p.m. Pacific Time in San Francisco,
California. The presentation will include an overview of the
company, current products, product pipeline and recent financial
performance; and will be webcast and accessible on Cholestech's
website at http://www.cholestech.com/. About Cholestech Cholestech
is committed to enabling people to lead longer, healthier and more
active lives. Cholestech provides easy to use, accessible
diagnostic tools and information to health care practitioners in
over 35 countries around the world. Cholestech offers efficient and
economic diagnostic testing for cholesterol and related lipids,
blood glucose and glycemic control, high sensitivity C-reactive
protein and liver enzymes at the point of care. Health care
providers can use the CLIA-waived Cholestech LDX(R) and GDX(TM)
Systems and the hs-CRP test, which is cleared by the FDA for use in
moderate complexity labs, to initiate and monitor the progress of
patient therapy. By providing effective disease management
solutions, Cholestech's goal is to be a leading provider of
diagnostic tools and information for immediate risk assessment and
therapeutic monitoring of heart disease and diabetes. Cholestech
LDX(R) is a registered trademark and Cholestech GDX(TM) is a
trademark of Cholestech Corporation. All other trademarks mentioned
in this document are the property of their respective owners. For
more information about Cholestech and its products visit us on the
web at http://www.cholestech.com/. DATASOURCE: Cholestech
Corporation CONTACT: Jack Glenn, Chief Financial Officer of
Cholestech Corporation, +1-510-781-5065, or ; or Brendan Lahiff of
Financial Dynamics, +1-415-439-4504, or , for Cholestech
Corporation Web site: http://www.cholestech.com/
Copyright
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Global X CleanTech ETF (NASDAQ): 0 Nachrichtenartikel
Weitere Cholestech (MM) News-Artikel